US Venture Partners X LP's Form 4 filing
eFFECTOR Therapeutics, Inc. (EFTR) · filed Nov 17, 2021
- Accession no.
- 0001062993-21-011097
- Filed
- Nov 17, 2021, 7:55 PM ET
- Trade date
- Nov 15-17, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $221.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| US Venture Partners X LPCIK 0001440514 | 10% Owner |
| Usvp X Affiliates LPCIK 0001453359 | 10% Owner |
| Tansey Casey MCIK 0001474322 | 10% Owner |
| Presidio Management Group X LLCCIK 0001602744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Common Stock | SSaleDisposed | −4,914 | $9.81 | −$48,211.25 | 4,583,604 | Indirect | |
| Nov 15, 2021 | Common Stock | SSaleDisposed | −157 | $9.81 | −$1,540.01 | 146,637 | Indirect | |
| Nov 16, 2021 | Common Stock | SSaleDisposed | −8,062 | $9.42 | −$75,935.98 | 4,575,542 | Indirect | |
| Nov 16, 2021 | Common Stock | SSaleDisposed | −257 | $9.42 | −$2,420.94 | 146,380 | Indirect | |
| Nov 17, 2021 | Common Stock | SSaleDisposed | −9,918 | $9.13 | −$90,521.59 | 4,565,624 | Indirect | |
| Nov 17, 2021 | Common Stock | SSaleDisposed | −317 | $9.13 | −$2,893.58 | 146,063 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.